| 177Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis MS Sadaghiani, S Sheikhbahaei, RA Werner, KJ Pienta, MG Pomper, ... The Prostate 82 (7), 826-835, 2022 | 28 | 2022 |
| 18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies S Sheikhbahaei, KM Jones, RA Werner, RA Salas-Fragomeni, CV Marcus, ... Annals of nuclear medicine 33, 351-361, 2019 | 64 | 2019 |
| 18F FDG PET/CT and head and neck cancer: Patient management and outcomes S Sheikhbahaei, C Marcus, RM Subramaniam PET clinics 10 (2), 125-145, 2015 | 30 | 2015 |
| 18F-FDG PET/CT and melanoma: value of fourth and subsequent posttherapy follow-up scans for patient management E Mena, M Taghipour, S Sheikhbahaei, S Mirpour, J Xiao, ... Clinical nuclear medicine 41 (9), e403-e409, 2016 | 17 | 2016 |
| 18F-FDG PET/CT for response assessment in lung cancer C Marcus, SH Tajmir, SP Rowe, S Sheikhbahaei, LB Solnes Seminars in Nuclear Medicine 52 (6), 662-672, 2022 | 4 | 2022 |
| 18F-FDG PET/CT in Screening for Occult Malignancy in Patients with presumed Paraneoplastic Syndromes. RS Fragomeni, R Wray, S Sheikhbahaei, M Javadi, S Rowe, L Solnes Journal of Nuclear Medicine 58 (supplement 1), 454-454, 2017 | 1 | 2017 |
| 18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual–Time Point and Segmentation Methods E Mena, S Sheikhbahaei, M Taghipour, AK Jha, E Vicente, J Xiao, ... Clinical nuclear medicine 42 (1), e16-e21, 2017 | 26 | 2017 |
| 18F-FDG PET/CT: therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients S Sheikhbahaei, E Mena, C Marcus, R Wray, M Taghipour, ... Journal of Nuclear Medicine 57 (6), 855-860, 2016 | 55 | 2016 |
| 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma S Sheikhbahaei, R Wray, B Young, E Mena, M Taghipour, A Rahmim, ... Nuclear Medicine Communications, 2015 | | 2015 |
| 18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction S Sheikhbahaei, R Wray, B Young, E Mena, M Taghipour, A Rahmim, ... Nuclear medicine communications 37 (3), 231-238, 2016 | 23 | 2016 |
| 2-Deoxy-2-[18F] Fluoro-d-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer S Sheikhbahaei, RM Subramaniam, LB Solnes PET clinics 17 (2), 307-317, 2022 | | 2022 |
| 477 Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Nonesmall-cell Lung Cancer Apostolia M. Tsimberidou, Sheryl Elkin, Robert Dumanois, Daryl … AS Mansfield, S Sheikhbahaei, F Verde, RK Hales, SP Rowe, LB Solnes | | |
| A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction A Rahmim, CR Schmidtlein, A Jackson, S Sheikhbahaei, C Marcus, ... Physics in Medicine & Biology 61 (1), 227, 2015 | 32 | 2015 |
| A practical guide to the pearls and pitfalls of PSMA PET imaging AF Voter, RA Werner, H Savas, A Gafita, AE Ross, MA Gorin, LB Solnes, ... Seminars in Nuclear Medicine, 2023 | 1 | 2023 |
| A systematic review and meta-analysis of the effectiveness and toxicities of lutetium-177–labeled prostate-specific membrane antigen–targeted radioligand therapy in metastatic … MS Sadaghiani, S Sheikhbahaei, RA Werner, KJ Pienta, MG Pomper, ... European urology 80 (1), 82-94, 2021 | 72 | 2021 |
| An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic … A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ... Neurological Sciences 36, 1121-1126, 2015 | 86 | 2015 |
| Anti–NMDA-Receptor Encephalitis ME Klontzas, C Kearns, S Sheikhbahaei, P Cornejo RadioGraphics 42 (7), E199-E200, 2022 | | 2022 |
| Application of Quantitative SPECT-CT reconstructions with 99mTc-sestamibi renal imaging of patients with cT1 renal masses. K Jones, S Sheikhbahaei, L Solnes, M Gorin, T Higuchi, S Rowe, M Allaf, ... Journal of Nuclear Medicine 58 (supplement 1), 745-745, 2017 | | 2017 |
| Applications of artificial intelligence in oncologic 18F-FDG PET/CT imaging: a systematic review MS Sadaghiani, SP Rowe, S Sheikhbahaei Annals of Translational Medicine 9 (9), 2021 | 43 | 2021 |
| Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes B Heidari, AA Nargesi, N Hafezi-Nejad, S Sheikhbahaei, A Pajouhi, ... American heart journal 170 (3), 573-579. e5, 2015 | 63 | 2015 |